Global Lung Stent Market Size and Trends

The global lung stent market size is expected to reach US$ 333.8 Mn by 2030, from US$ 206.5 Mn in 2023, growing at a CAGR of 7.1% during the forecast period. Lung stents are tiny mesh tubes that are inserted into the airways of the lungs through a minor procedure called bronchoscopy. There are basically two main types of lung stents: metal stents and silicone stents. Metal stents are mostly made of nitinol, which is a nickel-titanium alloy known for its shape, memory, and flexibility. They are easy to place and provide adequate patency for up to a year. However, tissue growth through the mesh can cause complications. Silicone stents are made of medical-grade silicone and are less prone to tissue growth. However, they are a bit harder to place accurately due to their physical properties.

Global Lung Stent Market Trends:

Consolidation among market players: Consolidation has been an ongoing trend in the lung stent market over the past few years. Major players have been acquiring smaller competitors to expand their product portfolios and geographic reach. This allows companies to benefit from synergies and economies of scale. For example, in 2021, Boston Scientific, one of the leading innovator of less invasive medical solutions acquired Devoro Medical, is a developer of a medical device, adding several bronchoscopic lung volume reduction products to their offerings. This strengthened Boston Scientific's position in the bronchoscopic lung volume reduction space. Another example is Cook Medical's acquisition of various esophageal stent assets from Taewoong Medical in 2022. This enhanced Cook's product lines for lung-related conditions.
Rising demand for silicone and hybrid stents: The rising demand for silicone and hybrid stents is having a significant impact on the lung stent market. These newer generation stents are increasingly becoming the preferred options for lung stent procedures owing to their various clinical benefits over traditional metal stent designs. Silicone and hybrid stents offer improved biocompatibility and a reduced risk of stent fractures as their material is more flexible than metal. This allows them to adapt better to the dynamic lung environment and natural body movements. The improved compliance of these stents results in superior sealing of air leak sites and enhanced efficacy in maintaining bronchial patency over longer periods of time. They also cause minimal injury to the lung tissue during insertion and retrieval processes due to their softer material.
Increasing popularity of personalized stents: The increasing popularity of personalized stents is having a major influence on the lung stent market. Traditional stents are manufactured in standard sizes and may not perfectly fit every patient's anatomy. However, personalized stents are specifically tailored for each patient based on scans of their individual airways. This allows the stents to be placed with optimal precision and minimizes issues like migration or blockage over time. The popularity of personalized stents is driven by the superior clinical outcomes they provide compared to traditional stents. Several recent studies have demonstrated the benefits of personalized stents. For example, a 2021 study published in the Journal of Thoracic Disease looked at 104 patients in U.S. receiving either personalized or standard stents to treat malignant central airway obstruction. It found that personalized stents led to significantly higher rates of clinical success, with 94.2% of blockages being completely resolved compared to 84.6% for standard stents. Complication rates were also lower with personalized stents.